China Pharma Holdings, Inc. (CPHI) financial statements (2022 and earlier)

Company profile

Business Address 2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE, 570216
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,8599581,0751,1872,0302,6666,249
Cash and cash equivalents4,8599581,0751,1872,0302,6666,249
Receivables 5026359172,253(15,664)5,883
Inventory, net of allowances, customer advances and progress billings3,3403,7053,5895,0556,4077,3119,663
Inventory3,3403,7053,5895,0556,4077,3119,663
Prepaid expense597477124186226339
Other undisclosed current assets836842031,4651,41422,9812,824
Total current assets:9,0935,3225,5798,74712,29017,52024,957
Noncurrent Assets
Operating lease, right-of-use asset12850137
Property, plant and equipment13,28115,56416,31419,29423,54124,96729,393
Intangible assets, net (including goodwill)148182206266399535841
Intangible assets, net (excluding goodwill)148182206266399535841
Other undisclosed noncurrent assets   17,07023,72335,49842,031
Total noncurrent assets:13,55615,79616,65636,63047,66361,00072,265
TOTAL ASSETS:22,65021,11822,23545,37759,95378,52097,222
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:8424,1605,1174,4374,2765,7034,678
Accounts payable2,8113,9834,9274,1264,0005,5634,535
Accrued liabilities298177190311276140143
Other undisclosed accounts payable and accrued liabilities(2,268)      
Deferred revenue210720 
Debt4,3294,3372,2412,1812,3051,4406,163
Due to related parties2,070 2,0721,6331,3551,3551,355
Customer advances and deposits581811596
Other liabilities2,7802,134     
Other undisclosed current liabilities283526151,8007101,089 
Total current liabilities:10,51311,40410,04510,0519,22710,39812,791
Noncurrent Liabilities
Long-term debt and lease obligation5,2949042,1994,3636,916  
Long-term debt, excluding current maturities5,2509042,1504,3636,916  
Operating lease, liability44 49
Liabilities, other than long-term debt824806 764738 297
Deferred tax liabilities, net764738 297
Deferred income tax liabilities824806 
Other undisclosed noncurrent liabilities  753  9,21311,493
Total noncurrent liabilities:6,1191,7102,9525,1277,6549,21311,790
Total liabilities:16,63213,11312,99815,17916,88219,61124,581
Stockholders' equity
Stockholders' equity attributable to parent, including:6,0188,0059,23830,19943,07158,90972,641
Common stock47464444444444
Additional paid in capital25,64524,45323,59023,59023,59023,59023,590
Accumulated other comprehensive income12,56412,34511,57611,83513,958  
Retained earnings (accumulated deficit)(32,239)(28,839)(25,972)(5,270)5,48024,75733,940
Other undisclosed stockholders' equity attributable to parent     10,51815,067
Total stockholders' equity:6,0188,0059,23830,19943,07158,90972,641
TOTAL LIABILITIES AND EQUITY:22,65021,11822,23545,37759,95378,52097,222

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues9,64210,86610,92412,33113,21215,57120,352
Cost of revenue(9,293)(8,914)(9,442)(10,356)(10,744)(12,352)(15,778)
Cost of goods and services sold  (253)(954)(118) (3,109)
Gross profit:3491,9531,4821,9752,4693,2194,573
Operating expenses(3,210)(4,531)(21,890)(12,422)(21,149)(11,717)(17,405)
Other operating income (expense), net
(Other Expenses)
     719(1,045)
Other undisclosed operating loss     (376)(423)
Operating loss:(2,861)(2,578)(20,408)(10,447)(18,680)(8,155)(14,300)
Nonoperating income (expense)(539)(288)(294)(413)(475)131120
Investment income, nonoperating36283964131120
Interest and debt expense(280)(294)(322)(451)(539)850(1,165)
Loss from continuing operations before equity method investments, income taxes:(3,679)(3,161)(21,024)(11,311)(19,694)(7,175)(15,345)
Other undisclosed income (loss) from continuing operations before income taxes280294322451539(1,699) 
Loss from continuing operations before income taxes:(3,399)(2,867)(20,702)(10,860)(19,155)(8,874)(15,345)
Income tax expense (benefit)   110(123)(308)60
Net loss:(3,399)(2,867)(20,702)(10,750)(19,278)(9,183)(15,285)
Other undisclosed net loss attributable to parent      (121)
Net loss available to common stockholders, diluted:(3,399)(2,867)(20,702)(10,750)(19,278)(9,183)(15,406)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(3,399)(2,867)(20,702)(10,750)(19,278)(9,183)(15,285)
Other comprehensive loss    (15,838)(13,732)(20,099)
Comprehensive loss:(3,399)(2,867)(20,702)(10,750)(35,115)(22,915)(35,384)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent218769(259)(2,122)   
Comprehensive loss, net of tax, attributable to parent:(3,181)(2,098)(20,961)(12,873)(35,115)(22,915)(35,384)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: